Page 59 - CIBEREHD2016-ENG

Most relevant scientific articles
• Vergara M., Sicilia B., Prieto L., Casellas F., Ramos A., Gomollon F. et al. Development and validation of the short Crohn’s disease work disability questionnaire. Inflammatory Bowel Diseases. 2016;22(4):955-962.
• Palau M., Kulmann M., Ramirez-Lazaro M.J., Lario S., Quilez M.E., Campo R. et al. Usefulness of Housekeeping Genes for the Diagnosis of Helicobacter pylori Infection, Strain Discrimination and Detection of Multiple Infection. Helicobacter. 2016.
• Puig I., Baylina M., Sanchez-Delgado J., Lopez-Gongora S., Suarez D., Garcia-Iglesias P. et al. Systematic review and meta-analysis: Triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment. Journal of Antimicrobial Chemotherapy. 2016;71(10):2740-2753.
• Ramírez-Lázaro MJ, Lite J, Lario S, Pérez-Jové P, Montserrat A, Quílez ME et al. Good diagnostic accuracy of a chemiluminescent immunoassay in stool samples for diagnosis of Helicobacter pylori infection in patients with dyspepsia.Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2016;64(2):388-91.
• Kuligowski J., Sanjuan-Herraez D., Vazquez-Sanchez M.A., Brunet-Vega A., Pericay C., Ramirez- Lazaro M.J. et al. Metabolomic analysis of gastric cancer progression within the Correa’s cascade using ultraperformance liquid chromatography-mass spectrometry. Journal of Proteome Research. 2016;15(8):2729-2738.
Hightlights
The most relevant achievements of 2016 of the Research Group of Parc Taulí Hospital of Sabadell were as follows:
Regarding the development of projects, we would highlight the different group’s lines of work: In the line of research on infection by Helicobacter, we would highlight the development of a systematic review on the utility of increasing the dose of PPI for Helicobacter pylori eradication. Regarding the projects of the research line on quality of life, we would highlight the development of indicators of quality of care for patients with inflammatory bowel disease, developed and evaluable by patients without intervention of care providers.
Regarding the description of the results obtained, we would highlight the first publications of CIBEREHD researchers with other basic research groups, from University of Barcelona and University of Valencia. These publications reflect, on the one hand, the consolidation of the basic and translational research group and, on the other hand, the establishment of a network with basic researchers from the rest of the state to promote research on H. pylori and on the early detection of gastric cancer. Another important achievement to note is that the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis
has adapted the quality standards established by our group, in collaboration with other groups from CIBEREHD, to certify the units of care attention in inflammatory bowel disease. Guidelines: During 2016, members of the group participated in the IV Spanish Consensus on the treatment of H. pylori (Emili Gené, Xavier Calvet), and in the following position papers of the Societat Catalana de Digestologia: upper non- variceal haemorrhage ( Rafel Campo, coordinator, Xavier Calvet, Emili Gene participants), management of H. pylori infection (Jordi Sánchez, Emili Gene participants, Xavier Calvet, coordinator), autoimmune liver diseases (Mercè Vergara).
EHD
research Groups 59